Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6701
Pixelworks
PXLW
$42.2M
| $98K | ﹤0.01% |
1,751
+872
| +99% | +$39.6K |
2016 Q4
1 quarter
|
|
6702
SCYNEXIS
SCYX
$50.1M
| $98K | ﹤0.01% |
+443
| New | +$112K |
2017 Q1
0 quarters
|
|
|
SALE
6703
CALL
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $97K | ﹤0.01% |
12,000
-16,300
| -58% | -$144K |
2016 Q3
2 quarters
|
|
|
IMGN
6704
PUT
DELISTED
Immunogen Inc
IMGN
| $96K | ﹤0.01% |
24,700
-7,800
| -24% | -$22.8K |
2013 Q2
15 quarters
|
|
|
CIVI
6705
DELISTED
Civitas Resources
CIVI
| $95K | ﹤0.01% |
736
-218
| -23% | -$43.8K |
2016 Q4
1 quarter
|
|
6706
PUT
Novavax
NVAX
$1.78B
| $95K | ﹤0.01% |
3,725
-1,585
| -30% | -$43.6K |
2013 Q2
15 quarters
|
|
6707
Vuzix
VUZI
$252M
| $95K | ﹤0.01% |
+15,277
| New | +$98.8K |
2017 Q1
0 quarters
|
|
|
LGCY
6708
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
| $95K | ﹤0.01% |
41,445
-16,383
| -28% | -$37K |
2014 Q4
9 quarters
|
|
6709
Anavex Life Sciences
AVXL
$162M
| $94K | ﹤0.01% |
+16,293
| New | +$84.1K |
2017 Q1
0 quarters
|
|
|
BRW
6710
Saba Capital Income & Opportunities Fund
BRW
$305M
| $94K | ﹤0.01% |
+8,651
| New | +$95.7K |
2017 Q1
0 quarters
|
|
|
TEN
6711
PUT
Tsakos Energy Navigation Ltd
TEN
$1.52B
| $94K | ﹤0.01% |
3,940
+100
| +3% | +$2.38K |
2015 Q4
5 quarters
|
|
|
KERX
6712
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $94K | ﹤0.01% |
15,300
-73,500
| -83% | -$403K |
2013 Q2
15 quarters
|
|
|
IIP
6713
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $94K | ﹤0.01% |
+25,303
| New | +$94K |
2017 Q1
0 quarters
|
|
|
VG
6714
PUT
DELISTED
Vonage Holdings Corporation
VG
| $94K | ﹤0.01% |
14,900
+4,200
| +39% | +$28K |
2016 Q4
1 quarter
|
|
6715
PUT
MidCap Financial Investment
MFIC
$704M
| $93K | ﹤0.01% |
4,733
-2,200
| -32% | -$40.8K |
2016 Q4
1 quarter
|
|
|
HSTO
6716
DELISTED
Histogen Inc. Common Stock
HSTO
| $93K | ﹤0.01% |
81
-62
| -43% | -$59.9K |
2016 Q2
3 quarters
|
|
|
BBOX
6717
PUT
DELISTED
Black Box Corp
BBOX
| $93K | ﹤0.01% |
+10,400
| New | +$112K |
2017 Q1
0 quarters
|
|
|
GCI
6718
CALL
DELISTED
Gannett Co., Inc
GCI
| $93K | ﹤0.01% |
+11,100
| New | +$99.2K |
2017 Q1
0 quarters
|
|
|
AMRN
6719
CALL
Amarin Corp
AMRN
$258M
| $92K | ﹤0.01% |
1,440
-1,595
| -53% | -$101K |
2016 Q2
3 quarters
|
|
6720
CALL
Cerus
CERS
$459M
| $92K | ﹤0.01% |
20,600
-7,100
| -26% | -$30.1K |
2014 Q4
9 quarters
|
|
6721
CALL
Celldex Therapeutics
CLDX
$2.51B
| $92K | ﹤0.01% |
1,707
-6,986
| -80% | -$364K |
2013 Q2
15 quarters
|
|
6722
PUT
Constellium
CSTM
$3.42B
| $92K | ﹤0.01% |
+14,100
| New | +$101K |
2017 Q1
0 quarters
|
|
6723
CALL
Gerdau
GGB
$10B
| $92K | ﹤0.01% |
33,768
+20,916
| +163% | +$65K |
2016 Q4
1 quarter
|
|
6724
NovoCure
NVCR
$1.76B
| $92K | ﹤0.01% |
11,391
-5,331
| -32% | -$38.5K |
2016 Q4
1 quarter
|
|
|
AVID
6725
PUT
DELISTED
Avid Technology Inc
AVID
| $92K | ﹤0.01% |
+19,700
| New | +$102K |
2017 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.